Shim Clinic Logo

Benign Prostatic Hyperplasia, Singapore - Shim Clinic

Benign prostatic hyperplasia

Latest News

Boston Scientific & #039;s Aggressive M & amp;A Strategy Continues with Augmenix Deal
Fri, 07 Sep 2018 22:12:07 +0800 | MDDI
Tuck-in acquisitions continue to play a key role in Boston Scientific's strategy this year, as evidenced by the company's latest deal, which also happens to be its largest so far in 2018.  The Marlborough, MA-based company has agreed to pay $500 million upfront and up to $100 million for sales-based milestones to acquire Augmenix. This private company is based in Bedford, MA and has developed a product called SpaceOAR, which intended to reduce common and debilitating side effects for men who undergo prostate cancer radiotherapy. Not only is Augmenix the eighth acquisition Boston Scientific has reported this year, it is the company's third acquisition in the urology and pelvic health space. The company aims to be category leaders in each space it participates in, says Dave Pierc...

Boston Scientific puts up $600m for Augmenix
Fri, 07 Sep 2018 19:35:00 +0800 | Mass Device
Boston Scientific (NYSE:BSX) said yesterday that it put $600 million on the table for Augmenix and its SpaceOar device. The deal for Bedford, Mass.-based Augmenix calls for $500 million in up-front cash and another $100 million pegged to sales-based milestones, Boston said. The SpaceOar hydrogel device, which won CE Mark approval in the European Union in 2010 and 510(k) clearance from the FDA in April 2015 , is designed to separate the prostate from the rectal wall during radiation treatment for prostate cancer. The product is delivered through a small needle as a liquid, which then solidifies into a soft gel that expands the space between the prostate and rectum during radiotherapy. After about three months, the substance begins to liquefy and is absorbed and cleared from the body in ...

Surgery-First Strategy Cost-Effective in Benign Prostatic Hyperplasia Surgery-First Strategy Cost-Effective in Benign Prostatic Hyperplasia
Fri, 31 Aug 2018 02:54:53 +0800 | Medscape Medical News Headlines
Using surgery as an initial treatment for moderate-to-severe benign prostatic hyperplasia (BPH) is more economically attractive than upfront pharmacotherapy followed by surgery for those who fail, researchers from Canada report.Reuters Health Information (Source: Medscape Medical News Headlines)

Study examines relationship between social disparities and benign prostatic hyperplasia
Wed, 22 Aug 2018 11:00:00 +0800 | EurekAlert! - Medicine and Health
(Wiley) In an Andrologia study of 100,000 men in Korea, social disparities -- such as low education level and low household income, current or previous use of medical aid health insurance, blue-collar employment or unemployment, divorce, and low social capital of communities -- were all linked with a higher prevalence of benign prostatic hyperplasia (BPH), a condition that is characterized by an enlarged prostate due to aging, lower urinary tract blockage, and other factors. (Source: EurekAlert! - Medicine and Health)

Aquablation May Improve Symptoms in Men With Large Prostates Aquablation May Improve Symptoms in Men With Large Prostates
Tue, 14 Aug 2018 12:33:14 +0800 | Medscape General Surgery Headlines
Aquablation, which uses robotically guided waterjets to remove excess prostate tissue, appears to improve lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH) and large prostate glands, researchers report.Reuters Health Information (Source: Medscape General Surgery Headlines)

OmniGuide to buy German urological laser-maker
Mon, 06 Aug 2018 23:19:54 +0800 | Mass Device
OmniGuide (Cambridge, Mass.) plans to acquire Lisa Laser Products, a surgical laser company based in Katlenburg-Lindau, Germany. Terms were not disclosed. Lisa Laser’s product portfolio consists of laser hardware units, laser fibers, endoscopes and other accessories for laser-assisted surgery. The company has been developing surgical laser technologies consisting of both thulium and holmium lasers for the treatment of benign prostatic hyperplasia, since 1989. More than half of men in the United States will develop the condition by age 60, and 30 million already have it, according to the American Urological Association. Get the full story on our sister site, Medical Design & Outsourcing. The post OmniGuide to buy German urological laser-maker appeared first on MassDevice. (Source: M...

Medical News Today: What are the treatment options for BPH?
Thu, 12 Jul 2018 23:00:00 +0800 | Health News from Medical News Today
Benign prostatic hyperplasia, or BPH, is the medical term for an enlarged prostate. BPH can cause difficulties with urination. Treatment options for BPH include watchful waiting, medication, minimally invasive procedures, and surgery. Lifestyle changes can also help improve a person ’s symptoms. Learn more here. (Source: Health News from Medical News Today)

New treatment option available for men suffering from benign prostatic hyperplasia
Mon, 09 Jul 2018 11:00:00 +0800 | EurekAlert! - Cancer
(University of California - San Diego) Physicians at UC San Diego Health are now offering prostate artery embolization as a new treatment option for men with benign prostatic hyperplasia, or an enlarged prostate. The minimally invasive procedure is an alternative to surgery, with no hospital stay, little operative pain and lower cost. (Source: EurekAlert! - Cancer)

Zydus Cadila gets USFDA nod for prostate condition treatment drug
Fri, 25 May 2018 07:00:00 +0800 | The Economic Times Healthcare and Biotech News
The drug is used to treat symptoms of Benign Prostatic Hyperplasia (BPH) -- also called prostate gland enlargement. (Source: The Economic Times Healthcare and Biotech News)

Medical News Today: Can saw palmetto reduce enlarged prostate?
Fri, 25 May 2018 02:00:00 +0800 | Health News from Medical News Today
Saw palmetto is an herbal remedy with many potential uses in healthcare. One such use is the treatment of benign prostate hyperplasia (BPH). Although a popular remedy, research into the herb ’s efficacy is still ongoing and the results to date are inconclusive. Here, we look at the other treatments also available. (Source: Health News from Medical News Today)

Related Concepts

Private & Confidential Service